These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 11171023

  • 1. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections.
    Langermann S, Ballou WR.
    J Infect Dis; 2001 Mar 01; 183 Suppl 1():S84-6. PubMed ID: 11171023
    [No Abstract] [Full Text] [Related]

  • 2. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.
    Langermann S, Möllby R, Burlein JE, Palaszynski SR, Auguste CG, DeFusco A, Strouse R, Schenerman MA, Hultgren SJ, Pinkner JS, Winberg J, Guldevall L, Söderhäll M, Ishikawa K, Normark S, Koenig S.
    J Infect Dis; 2000 Feb 01; 181(2):774-8. PubMed ID: 10669375
    [Abstract] [Full Text] [Related]

  • 3. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.
    Palaszynski S, Pinkner J, Leath S, Barren P, Auguste CG, Burlein J, Hultgren S, Langermann S.
    Dev Biol Stand; 1998 Feb 01; 92():117-22. PubMed ID: 9554264
    [Abstract] [Full Text] [Related]

  • 4. New vaccines may ward off urinary tract infections.
    Service RF.
    Science; 1997 Apr 25; 276(5312):533. PubMed ID: 9148412
    [No Abstract] [Full Text] [Related]

  • 5. Structure and function of Escherichia coli type 1 pili: new insight into the pathogenesis of urinary tract infections.
    Schilling JD, Mulvey MA, Hultgren SJ.
    J Infect Dis; 2001 Mar 01; 183 Suppl 1():S36-40. PubMed ID: 11171011
    [No Abstract] [Full Text] [Related]

  • 6. Immune response against adhesins of enteroaggregative Escherichia coli immunized by three different vaccination strategies (DNA/DNA, Protein/Protein, and DNA/Protein) in mice.
    Bouzari S, Dashti A, Jafari A, Oloomi M.
    Comp Immunol Microbiol Infect Dis; 2010 May 01; 33(3):215-25. PubMed ID: 19022502
    [Abstract] [Full Text] [Related]

  • 7. [New findings on alpha-hemolytic strains of E. coli in urinary tract infections. I. alpha-hemolysin and adhesins].
    Dŭrovicová J, Puzová H, Janigová V.
    Cesk Epidemiol Mikrobiol Imunol; 1992 Jun 01; 41(2):78-81. PubMed ID: 1354572
    [Abstract] [Full Text] [Related]

  • 8. Microbiology. Pods invade infected bladders.
    Ferber D.
    Science; 2003 Jul 04; 301(5629):31. PubMed ID: 12843366
    [No Abstract] [Full Text] [Related]

  • 9. Vaccination with purified Dr Fimbriae reduces mortality associated with chronic urinary tract infection due to Escherichia coli bearing Dr adhesin.
    Goluszko P, Goluszko E, Nowicki B, Nowicki S, Popov V, Wang HQ.
    Infect Immun; 2005 Jan 04; 73(1):627-31. PubMed ID: 15618205
    [Abstract] [Full Text] [Related]

  • 10. [Candidate vaccine against urinary tract infections].
    Hoepelman IM, Meiland R, Langermann S.
    Ned Tijdschr Geneeskd; 2001 Sep 22; 145(38):1860-2. PubMed ID: 11593791
    [Abstract] [Full Text] [Related]

  • 11. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.
    Asadi Karam MR, Oloomi M, Mahdavi M, Habibi M, Bouzari S.
    Vaccine; 2013 Feb 06; 31(8):1210-6. PubMed ID: 23306365
    [Abstract] [Full Text] [Related]

  • 12. Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains.
    Restieri C, Garriss G, Locas MC, Dozois CM.
    Appl Environ Microbiol; 2007 Mar 06; 73(5):1553-62. PubMed ID: 17220264
    [Abstract] [Full Text] [Related]

  • 13. [Effects of vaccination in urinary infections caused by Escherichia coli in rats].
    Mathieu D, Jacques L, Auer J, Bizzini B.
    Biomed Pharmacother; 1987 Mar 06; 41(8):442-5. PubMed ID: 3330459
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Escherichia coli infections.
    Levine MM.
    N Engl J Med; 1985 Aug 15; 313(7):445-7. PubMed ID: 2862583
    [No Abstract] [Full Text] [Related]

  • 16. A new candidate vaccine for Escherichia coli pyelonephritis.
    Stapleton A.
    J Urol; 2004 Apr 15; 171(4):1686-7. PubMed ID: 15017267
    [No Abstract] [Full Text] [Related]

  • 17. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
    Dima VF, Ionescu MD, Palade R, Balotescu C, Becheanu G, Dima SV.
    Roum Arch Microbiol Immunol; 2001 Apr 15; 60(1):27-54. PubMed ID: 11850896
    [Abstract] [Full Text] [Related]

  • 18. Development of an enteric-coated pellet formulation of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infections.
    Huyghebaert N, Snoeck V, Vermeire A, Cox E, Goddeeris BM, Remon JP.
    Eur J Pharm Biopharm; 2005 Feb 15; 59(2):273-81. PubMed ID: 15661499
    [Abstract] [Full Text] [Related]

  • 19. pap genotype and P fimbrial expression in Escherichia coli causing bacteremic and nonbacteremic febrile urinary tract infection.
    Otto G, Magnusson M, Svensson M, Braconier J, Svanborg C.
    Clin Infect Dis; 2001 Jun 01; 32(11):1523-31. PubMed ID: 11340521
    [Abstract] [Full Text] [Related]

  • 20. Intracellular bacterial biofilm-like pods in urinary tract infections.
    Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ.
    Science; 2003 Jul 04; 301(5629):105-7. PubMed ID: 12843396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.